Ayrton Capital LLC 13D and 13G filings for SUNESIS PHARMACEUTICALS INC CO:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 11:06 am Sale | 2020-12-31 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS | Ayrton Capital LLC | 0 0.000% | -10,869,565 (Position Closed) | Filing |
| 2020-08-07 2:51 pm Purchase | 2020-07-29 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS | Ayrton Capital LLC | 10,869,565 6.650% | 10,869,565 (New Position) | Filing |